Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
The Board of Directors of Hofseth BioCare ASA (the "Company") has resolved to appoint Christoph Baldegger as new member of the audit committee, and has further resolved to propose that the general...
-
The Extraordinary General Meeting in Hofseth BioCare ASA were held at the premises of the Company in Ålesund, Norway today Wednesday 11 November 2020. All proposals were approved. Please find the...
-
Ola Holen, chairman of the Board of Hofseth BioCare ASA (the "Company" or "HBC"), has in connection with the upcoming extraordinary general meeting on 11 November 2020, received proxy rights without...
-
During Q3 2020, Hofseth BioCare continued to develop along its strategic path of extracting high value nutrition and medical products from low value waste from salmon production, and invested...
-
Reference is made to the stock exchange announcement on 16 October 2020 regarding the completion of a private placement (the "Private Placement") in Hofseth BioCare ASA. The share capital increase...
-
Roger Hofseth AS, a company controlled by Roger Hofseth, has today 21 October 2020 bought 50,000 shares at an average price of 7.54 per share. Roger Hofseth is CEO and primary insider in Hofseth...
-
An Extraordinary General Meeting in Hofseth BioCare ASA will be held at the company's premises at Havnegata 11, 6005 Ålesund, on 11 November 2020 at 13:00 CET. Considering the travel and meeting...
-
Reference is made to the stock exchange notice on 6 October 2020. HBC has now received approval from Health Canada for Qualified Health Claims (QHCs) for its Salmon Protein Hydrolysate (ProGo® and...
-
Reference is made to the stock exchange notice from Hofseth BioCare ASA dated 16 October 2020 regarding the private placement of NOK 200m (the "Private Placement"). As a consequence of the Private...
-
Reference is made to the announcement by Hofseth BioCare ASA on 16 October 2020 concerning the completion of a private placement with total gross proceeds of approximately NOK 200 million and a...